0 Global Stem Cells Group to Share Latest Stem Cell Harvesting Techniques at 20th World Congress of Aesthetic Medicine in Miami

MIAMI, Oct. 26, 2015—Global Stem Cells Group, a world leader in regenerative medicine, has announced its participation in the 20th World Congress of Aesthetic Medicine, to be held at the JW Marriott in Miami Nov. 12-15, 2015. Faculty from Stem Cell Training, a GSCG subsidiary, will be sharing the latest hands-on techniques and protocols for in-office stem cell harvesting procedures.

The 20th World Congress of Aesthetic Medicine will gather aesthetic medicine experts and thought leaders from around the world to provide prospective on the industry’s future, and identify where key opportunities can be found. The theme of this conference, “Discoveries in Aesthetic Medicine,” is designed to educate practitioners on the latest procedures, products and technologies available in this fast-growing market.

Key stem cell medicine researchers, practitioners and industry insiders from around the world will gather to meet, network and participate in the congress, exhibition, social events, pre-congress courses and a post-congress CME Western Caribbean cruise. Simultaneous English-Spanish-English interpretation will be featured in the main conference room.

The American Academy of Aesthetic Medicine was selected by the UIME (Union Internationale de Médecine Esthétique/International Association of Aesthetic Medicine) to host the event. The popularity of minimally invasive aesthetic medicine procedures in a clinical setting has grown immensely in the U.S. and globally. The specialty is attracting a growing community of physicians and industry suppliers worldwide as opportunities in aesthetic medicine continue to proliferate.

For more information on the 20th World Congress of Aesthetic Medicine, visit the aaamed.org website, email bnovas(at)stemcellsgroup(dot)com, or call +1 305 560 5337.

About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Stem Cell Training, Inc.:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

About AAAM:

The American Academy of Aesthetic Medicine (AAAM) is dedicated to teaching physicians who have a scientific and clinical interest in exploring the aesthetic medicine element of their practice. AAAM teaches the art, science, techniques and procedures of aesthetic medicine to licensed physicians, regardless of specialty. AAAM provides education and hands-on training, and disseminates leading edge information gathered from advances in North America and around the world to its members.

AAAM has trained more than 5,000 doctors since 1999 from the United States, Mid-East, Asia, Australia, South Africa, and Europe. AAAM has conducted more than 300 courses including congresses across the globe since its inception. The AAAM is the exclusive USA member of the International Union of Aesthetic Medicine (UIME), which is comprised of 29 member societies and 30,000 members. AAAM’s President Emeritus Michel Delune, M.D. is one of the original four founding members of the UIME, and is founder of the American Academy of Aesthetic Medicine.

0 Augusto Brazzini, M.D., President of the Peruvian Society for Cellular Therapy, Will Appear as a Featured Lecturer at Global Stem Cells Group’s Buenos Aires Symposium Oct. 15

MIAMI, Oct. 5, 2015— Global Stem Cells Group has announced that Augusto Brazzini, M.D., president of the Peruvian Society for Cellular Therapy, will appear as a featured lecturer at the Global Stem Cells Group Buenos Aires Symposium on Oct. 15, 2015.

Brazzini, a renowned physician and stem cell scientist, also founded the Brazzini Institute of Interventional Radiology in San Isidro, Peru.  Brazzini will speak on the latest advancements in clinical applications for hematopoietic stem cells to treat Parkinson’s Disease and other chronic conditions.

He is also a professor at San Martin University in Lima, and vice president of  the Peruvian Association of Cell Therapy (APTCEL,) a scientific and educational association created in Peru to promote the study, research and application of adult stem cell therapy.

Dr. Brazzini received his medical degree from Federicoima,  Villarreal National University in 1977 and received additional training in radiology from San Marcos National University Police Peruvian Hospital and National Institute of Neoplasic Diseases.

For more information on the Global Stem Cells Group Buenos Aires symposium including the lineup of speakers, visit the stemcellconference.org website, emailbnovas@stemcellsgroup.com, or call +1 305 560 5337.

About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

###

0 Global Stem Cells Group and Burton Feinerman, M.D. to Offer New Stem Cell Therapies for Neurodegenerative Conditions

Global stem cells group and associate Burton Feinerman M.D. have announced plans to offer innovative stem cell therapies to treat patients with specific neurodegenerative conditions.

MIAMI AND TAMPA, FLA. (PRWEB) AUGUST 24, 2015

Global Stem Cells Group, has announced plans to collaborate with regenerative medicine specialist Burton Feinerman M.D. to offer new stem cell therapies that combine adult stem cells derived from adipose tissue, bone marrow and peripheral blood with differentiated cells and transference factors, using patented protocols developed by Feinerman.

The treatment protocols will target specific neurodegenerative conditions that primarily affect the neurons in the brain. Neurons are critical components of the nervous system, which includes the brain and spinal cord. When they become damaged die, neurons don’t reproduce or replace themselves. Examples of neurodegenerative diseases include Alzheimer’s and Parkinson’s disease.

Neurodegenerative diseases are incurable and debilitating conditions that lead to the progressive degeneration or death of nerve cells, causing difficulty with movement or mental function (dementia). According to a March, 2015 World Health Organization report, dementias are responsible for the greatest burden of disease with Alzheimer’s representing approximately 60-70 percent of cases.

Feinerman is a physician and research scientist specializing in stem cell therapies, ant-aging medicine and gene therapies to treat a variety of conditions and diseases. He is a member of the GSCG Advisory Board.
For more information on innovative stem cell therapies, visit the Global Stem Cells Group Website, email bnovas@stemcellsgroup.com, or call 305-224-1858.

About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

To learn more about Global Stem Cells Group, Inc.’s companies and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.

About Burton Feinerman, M.D.:

Burton Feinerman, M.D. an internationally recognized expert in stem cell and gene therapy, helped pioneer the earliest patents for regenerative medicine therapies. He has dedicated his medical career to improving the lives of patients through regenerative medicine.

Feinerman earned a medical degree from New York Medical College and completed his fellowship at the renowned Mayo Clinic in Rochester, Minnesota. He has been practicing medicine for more than half a century and has dedicated his practice to bettering the lives of his patients through regenerative medicine. Feinerman believes in challenging the incurable with regenerative medicine, and providing a new pathway to overall health and longevity.

Feinerman is a highly respected board certified physician and a member of numerous medical societies including the Society of Apheresis, the Society of Bone Marrow Blood Transplantation, the International Society of Cellular Therapy, the Society for Cranial Transplantation and Brain Repair, the Society for Cardiac Translational Therapy. He is a member of the Global Stem Cells Group Advisory Board.

0 Global Stem Cells Group Announces Canary Island Stem Cell Training Course

0 Stem Cell Training Achieves 2015 Goal, Training 402 Physicians in 27 Cities Worldwide

0 Global Stem Cells Group to Move Headquarters to Larger Miami Lakes Office Complex

Global Stem Cells Group has announced plans to move its expanding network of stem cell and regenerative medicine companies to larger offices in the Miami Lakes Corporate Center.

Citing fast-paced growth and the need for more space to accommodate its expanding operations, Global Stem Cells Group CEO Benito Novas has announced plans to move the organization’s headquarters from Sunrise, Florida to the Miami Lakes Corporate Center. The new location more than doubles the space for the international stem cell and regenerative medicine company’s corporate offices.

Since opening in 2012 under the Regenestem brand, Global Stem Cells Group and its six operating companies have grown exponentially, establishing partnerships with stem cell clinics, hospitals, researchers and physicians in the Philippines, South America and Europe.

“The new Global Stem Cells Group facility provides state-of-the-art space for our entire team to drive innovation through our research and development initiatives, and support partnering activities with our biotechnology products and education programs,” Novas says. “We now have the space to continue the fast-paced growth of our companies and advance the development of new stem cell and regenerative medicine technologies that will benefit patients worldwide.”

The new corporate headquarters, scheduled to open January 15, 2015, are located in the Miami Lakes Corporate Center, 14750 NW 77th Court, Suite 304 Miami Lakes, FL 33016.

0 Global Stem Cells Group Launches Stem Cell Conference Website Page for At-a-Glance Meeting and Conference information

0 Global Stem Cells Group Subsidiary Stem Cell Training Announces Training Course to Take Place in Porto Alegre, Brazil

STEM CELL TRAINING, INC. AND CO-SPONSOR JORGE GIOSCIA FILHO,M.D. ANNOUNCE PLANS TO CONDUCT THE FIRST STEM CELL TRAINING COURSE IN BRAZIL OCT. 24-25, 2015. THE TRAINING CLASS WILL BE HELD IN PORTO ALEGRE.

Stem Cell Training

Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct Brazil’s first ever stem cell harvesting and reintegration course Oct. 24 and 25, 2015. Through his alliance with Stem Cell Training, Inc. cardio-vascular surgeon Jorge Gioscia Filho, M.D. will conduct the Adipose and Bone Marrow Stem Cell Training Course for medical professionals in his home town of Poro Alegre.

In addition to his work in vascular and endovascular surgery, Filho has specialized in medical genital aesthetics in his private practice for more than 10 years. He is a member and professor at the Postgraduate Course in Aesthetic Medicine of IAAM-ASIME. Member of the International Society for Sexual Medicine and Vice President of the Southern Region of the Brazilian Society for Sexual Medicine, a member of the Brazilian Society of Angiology and Vascular Surgery, and a member of the International Society for Endovascular Specialists.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session to arm participating physicians with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.

The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Stem Cell Training, Inc.:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide

0 Global Stem Cells Group Announces Plans to Hold International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 3-4, 2015

The Global Stem Cells Group, Inc. has announced plans to host an international symposium on stem cells and regenerative medicine in Santiago, Chile Sept. 3-4, 2015. The Chile symposium is one of four to be hosted by GSCG this year in Latin America.

Global Stem Cells Group

The symposium will feature some of the world’s most prominent scientific experts in stem cell and regenerative medicine.

Global Stem Cells Group has announced plans to host an international symposium on stem cell research in Santiago, Chile. The symposium will feature some of the world’s most prominent scientific experts in stem cell and regenerative medicine, who will provide a full day of high-level scientific discussion for medical professionals in general practice.

The symposium agenda will include sessions on:

• Molecular biology
• Clinical advances in stem cell research
• Models of treatment in surgical and cosmetic applications, and in clinical conditions
• Technological advances
• Application of minimally manipulated stem cells in the physician’s office
• Stem cells, regenerative medicine and its application in anti-aging medicine
• Medical legal issues

The Santiago, Chile symposium includes a full day, hands-on training session to provide participating physicians and qualified medical professionals with state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells, along with clinical protocols. This popular training course is part of the Global Stem Cells Group’s commitment to the growing network of world-class stem cell researchers, treatment practitioners and investors committed to advancing stem cell medicine, and helping physicians bring treatments into the office for the benefit of patients.

The Santiago symposium will be held at Santo Tomas University in Santiago, Chile, and hosted by the Dean of Health Services Faculty, Fernando Espina Otero, M.D.

For more information on the Global Stem Cells Group Santiago, Chile symposium including the lineup of speakers, visit the stemcellconference.org website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

0 Global Stem Cells Group to Participate in the 15th International Congress of Aesthetic Surgery in Boca del Rio, Veracruz

More than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe will attend the four day event.

Charles Mahl, M.D. and David B. Audley will representGlobal Stem Cells Group, Inc. as keynote speakers at the 15th International Congress of Aesthetic Surgeryin Boca del Rio in Veracruz, Mexico July 9-12, 2015. Mahl, a member of the Global Stem Cells Group Scientific Advisory Board, and Audley, the chairman and general secretary of the Regentech Alliance (RTA), will join more than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe for the four day event.

Hosted by the Instituto de Estudios Superiores en Medicina (Institute of Advanced Studies in Medicine) in Veracruz, conference attendees will include an international lineup of physicians and medical practitioners in a variety of disciplines who will gather to discuss the newest therapies, protocols and innovative procedures available in aesthetic medicine.

Mahl, who maintains an active practice in regenerative medicine, preventive aging and pain therapies, will bring his expertise in prolotherapy, platelet rich plasma injections and stem cell therapies to the conference. Audley is a pioneer in the field of regenerative medicine and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies.

The conference will feature workshops in botulinum toxin applications for beginners and advanced students, and peeling treatments for stretch marks. Some of the topics to be addressed at the event include updates in aesthetic surgery, regenerative medicine therapies, platelet rich plasma applications, clinical and therapeutic stem cell applications, facial fillings, COFEPRIS guidelines, legal issues associated with aesthetic surgery and more.

The conference will take place at the Hotel Galerias Plaza Veracruz, Blvd. Adolfo Ruiz Cortines #3495, Costa Verde, Boca Del Río, Veracruz. For more information on the 15th International Congress of Aesthetic Surgery, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-560-5337.

About Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

About Charles Mahl, M.D.:

Charles F. Mahl, M.D. is a Miami-based specialist in regenerative medicine, preventive aging and pain therapies. His expertise includes prolotherapy, platelet rich plasma injections and stem cell therapies for a variety of painful orthopedic conditions and injuries involving (but not limited to) the back, sacroiliac joints, hips, knees, shoulders and neck. Mahl’s background as a vitreo-retinal surgeon prior to his training in regenerative medicine makes him eminently qualified to perform stem cell therapies on the eyes.

A member of the Global Stem Cells Group Scientific Advisory Board, Mahl sees stem cell therapies as medicine’s new frontier, offering unlimited possibilities for easing and eliminating many forms of disease and injury-related pain. He is licensed to practice medicine in Florida and Board Certified in Integrative Medicine. Mahl has completed multiple fellowships in age management medicine, and spent more than two years in a mentorship program for prolotherapy and regenerative injection medicine with Alvin Stein, M.D., a relationship that continues to this day. For Mahl’s full bio, visit http://www.stemcellsgroup.com/advisory-board/.

About David B. Audley:

David B. Audley serves as the Chair and General Secretary of the Regentech Alliance (RTA), a 501(c)3 backed by individuals and institutions who support the Regentech mission to bring peer oversight and transparency to the field of cell-based and regenerative medicine. Audley is a pioneer in the emerging field of regenerative medicine, and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies. Audley has taken a leadership role in drafting international standards and governmental regulations for the Cayman Islands and the Bahamas, and has worked with regulators in Mexico, the Kingdom of Jordan, and China to provide frameworks for physicians. Audley is a well-known lecturer who has spoken widely on varying topics dealing with the trends in patient care, the importance of oversight for investigational therapies, the emergence of regenerative medicine and the global and regulatory issues associated with medical tourism. For more information, visit http://regen-tech.org.